Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manuel Luna Santamaría"'
Autor:
Parmida Ranji, Emma Jonasson, Lisa Andersson, Stefan Filges, Manuel Luna Santamaría, Christoffer Vannas, Soheila Dolatabadi, Anna Gustafsson, Ola Myklebost, Joakim Håkansson, Henrik Fagman, Göran Landberg, Pierre Åman, Anders Ståhlberg
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Myxoid liposarcoma (MLS) displays a distinctive tumor microenvironment and is characterized by the FUS::DDIT3 fusion oncogene, however, the precise functional contributions of these two elements remain enigmatic in tumor developme
Externí odkaz:
https://doaj.org/article/efac96b56a16441ab22d151be2064aa6
Autor:
Manuel Luna Santamaría, Daniel Andersson, Toshima Z. Parris, Khalil Helou, Tobias Österlund, Anders Ståhlberg
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract Mutation analysis is typically performed at the DNA level since most technical approaches are developed for DNA analysis. However, some applications, like transcriptional mutagenesis, RNA editing and gene expression analysis, require RNA ana
Externí odkaz:
https://doaj.org/article/0e4df2b9e55c46e09023d14dc260def7
Autor:
Soheila Dolatabadi, Emma Jonasson, Lisa Andersson, Manuel Luna Santamaría, Malin Lindén, Tobias Österlund, Pierre Åman, Anders Ståhlberg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Myxoid liposarcoma is one of the most common sarcoma entities characterized by FET fusion oncogenes. Despite a generally favorable prognosis of myxoid liposarcoma, chemotherapy resistance remains a clinical problem. This cancer stem cell property is
Externí odkaz:
https://doaj.org/article/adf5270b00a744bfa928e2228023e756
Autor:
Soheila, Dolatabadi, Emma, Jonasson, Lisa, Andersson, Manuel, Luna Santamaría, Malin, Lindén, Tobias, Österlund, Pierre, Åman, Anders, Ståhlberg
Publikováno v:
Frontiers in oncology. 12
Myxoid liposarcoma is one of the most common sarcoma entities characterized by FET fusion oncogenes. Despite a generally favorable prognosis of myxoid liposarcoma, chemotherapy resistance remains a clinical problem. This cancer stem cell property is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::454c37d1489d3defaee02801de7c015c
https://pubmed.ncbi.nlm.nih.gov/35186752
https://pubmed.ncbi.nlm.nih.gov/35186752